Menu
GWAS Study

Immune and spermatogenesis-related loci are involved in the development of extreme patterns of male infertility.

Cerván-Martín M, Tüttelmann F, Lopes AM et al.

36357561 PubMed ID
GWAS Study Type
2731 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CM
Cerván-Martín M
TF
Tüttelmann F
LA
Lopes AM
BL
Bossini-Castillo L
RR
Rivera-Egea R
GN
Garrido N
LS
Lujan S
RG
Romeu G
SS
Santos-Ribeiro S
CJ
Castilla JA
CG
Carmen Gonzalvo M
CA
Clavero A
MV
Maldonado V
VF
Vicente FJ
GS
González-Muñoz S
GA
Guzmán-Jiménez A
BM
Burgos M
JR
Jiménez R
PA
Pacheco A
GC
González C
GS
Gómez S
AD
Amorós D
AJ
Aguilar J
QF
Quintana F
CC
Calhaz-Jorge C
AA
Aguiar A
NJ
Nunes J
SS
Sousa S
PI
Pereira I
PM
Pinto MG
CS
Correia S
SJ
Sánchez-Curbelo J
LO
López-Rodrigo O
MJ
Martín J
PI
Pereira-Caetano I
MP
Marques PI
CF
Carvalho F
BA
Barros A
GJ
Gromoll J
BL
Bassas L
SS
Seixas S
GJ
Gonçalves J
LS
Larriba S
KS
Kliesch S
PR
Palomino-Morales RJ
CF
Carmona FD
Chapter II

Abstract

Summary of the research findings

We conducted a genome-wide association study in a large population of infertile men due to unexplained spermatogenic failure (SPGF). More than seven million genetic variants were analysed in 1,274 SPGF cases and 1,951 unaffected controls from two independent European cohorts. Two genomic regions were associated with the most severe histological pattern of SPGF, defined by Sertoli cell-only (SCO) phenotype, namely the MHC class II gene HLA-DRB1 (rs1136759, P = 1.32E-08, OR = 1.80) and an upstream locus of VRK1 (rs115054029, P = 4.24E-08, OR = 3.14), which encodes a protein kinase involved in the regulation of spermatogenesis. The SCO-associated rs1136759 allele (G) determines a serine in the position 13 of the HLA-DRβ1 molecule located in the antigen-binding pocket. Overall, our data support the notion of unexplained SPGF as a complex trait influenced by common variation in the genome, with the SCO phenotype likely representing an immune-mediated condition.

780 European ancestry cases, 1,951 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

2731
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Portugal, Germany, Spain
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.